The E. coli AntiMicrobial Satellite(EcAMSat) mission will investigate space microgravity affects on the antibiotic resistance of E. coli, a bacterial pathogen responsible for urinary tract infection in humans and animals. EcAMSat is being developed through a partnership between NASAs Ames Research Center and the Stanford University School of Medicine. Dr. A.C. Matin is the Stanford University Principal Investigator. EcAMSat will investigate spaceflight effects on bacterial antibiotic resistance and its genetic basis. Bacterial antibiotic resistance may pose a danger to astronauts in microgravity, where the immune response is weakened. Scientists believe that the results of this experiment could help design effective countermeasures to protect astronauts health during long duration human space missions.


    Zugriff

    Zugriff über TIB

    Verfügbarkeit in meiner Bibliothek prüfen


    Exportieren, teilen und zitieren



    Titel :

    NASA FACTS: E. coli AntiMicrobial Satellite (EcAMSat)


    Beteiligte:
    Spremo, Stevan (Autor:in) / Cappuccio, Gelsomina (Autor:in) / Tomko, David (Autor:in)

    Erscheinungsdatum :

    2013-04-24


    Medientyp :

    Sonstige


    Format :

    Keine Angabe


    Sprache :

    Englisch




    E. coli AntiMicrobial Satellite (EcAMSat)

    Spremo, Stevan / Smith, Jeffrey D. / Tomko, David | NTRS | 2014



    NASA Facts: SporeSat

    A. Martinez / G. Cappuccio / D. Tomko | NTIS | 2013



    NASA Facts: SporeSat

    Martinez, Andres / Cappuccio, Gelsomina / Tomko, David | NTRS | 2013